By Max Bernhard 
 

Bayer AG (BAYN.XE) said Monday that it has made further concessions to European regulators as part of its $63.5 billion bid to acquire Monsanto Co (MON).

The German pharma company said it submitted "very significant" remedies to the European Commission and that it is confident the offered concessions fully address the regulator's concerns.

The European Commission said in a statement on its website that a review of the deal will be pushed to April 5, after Bayer made new concessions on Friday.

Bayer and the European Commission didn't give any further details of the concessions offered.

Write to Max Bernhard at Max.Bernhard@dowjones.com, @mxbernhard

(END) Dow Jones Newswires

February 05, 2018 07:22 ET (12:22 GMT)